Collegium Pharmaceutical, Inc. Common Stock (COLL)
Collegium Pharmaceutical, Inc. is a pharmaceutical company focused on developing and commercializing innovative medicines for patients with serious medical needs. It is known for its opioid receptor modulators and other pain management therapies, integrating science and technology to address pain treatment challenges.
Company News
Collegium Pharmaceutical, Inc. announced it will have two poster presentations highlighting real-world data from its ADHD treatment, Jornay PM, at the National Association of Pediatric Nurse Practitioners National Conference.
Throughout the last three months, 4 analysts have evaluated Collegium Pharmaceutical (NASDAQ:COLL), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewha...
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Small-cap stocks offer high growth but come with risk. Quant Ratings can find high-growth small-caps with solid fundamentals. Click here for 10 Small-Cap Stocks.